Skip to main content

Table 1 Analytic dataset

From: Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data

ID

Study

Treatment

Follow up (weeks)

Number patients

Mean duration (months)

Mean size (cm2)

Number healed

Evidence format available

16

Duby et al. 1993 [18]

4LB

12

25

20.5

11.9

11

AD

  

SSB

12

25

26.7

13.1

10

17

Scriven et al. 1998 [19]

4LB

52

32

13

13.3

17.6

AD

  

SSB

52

32

21

8.3

18.24

18

Partsch et al. 2001 [20]

4LB

16

53

1.25

1.5

33

AD

  

SSB

16

59

1

1.9

43

19

Ukat et al. 2003 [21]

4LB

12

44

--

17.7

13

AD

  

SSB

12

45

--

12.2

10

20

Franks et al. 2004 [22]

4LB

24

74

2

5

59

AD

  

SSB

24

82

2

3.5

62

21

Junger et al. 2004b [23]

SSB

12

60

5.57

5.95

19

AD

  

HH

12

61

4.14

5.62

29

22

Kralj et al. 1996 [24]

4LB

24

20

7.9

18.6

7

AD

  

Ad hoc: Ba

24

20

6.9

17.2

8

23

Polignano et al. 2004b [25]

4LB

24

39

--

10.1

29

AD

  

ZINC

24

29

--

9.3

19

24

Wilkinson et al. 1997 [26]

4LB

12

17

--

11.2

8

AD

  

Ad hoc: BHeH

12

18

--

8.6

8

25

Colgan et al. 1995 [27]

4LB

12

10

9.3

27.5

6

AD

  

Ad hoc: BzeaH

12

10

66.5

48.5

7

26

Blecken et al. 2005 [28]

4LB

12

12

--

50.08

4

AD

  

Ad hoc: HV

12

12

--

48.98

4

27

Moffatt et al. 2008 [29]

4LB

4

42

48.8

5.7

3

AD

  

2LB

4

39

46.6

11.8

6

28

Szewczyk et al. 2010 [30]

4LB

12

15

--

6

9

AD

  

2LB

12

16

--

5.3

10

29

Wong et al. 2012 [31]

4LB

24

107

--

--

72

AD

  

SSB

24

107

--

--

77

30

Iglesias et al. 2004 [32]

4LB

52

195

3

3.81

107

IPD

  

SSB

52

192

3

3.82

86

14

Ashby et al. 2013 [17]

4LB

52

224

12.29

9.30

157

IPD

  

HH

52

230

10.82

9.41

163

  1. AD – aggregate-level data; IPD – individual patient data; 4LB, SSB, HH, Zinc paste,2LB and the ad hoc systems Ba, BHeH, BzeaH, HV as described in Additional file 1.